Form 8-K - Current report:
SEC Accession No. 0001144204-15-064448
Filing Date
2015-11-12
Accepted
2015-11-12 10:06:05
Documents
2
Period of Report
2015-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v424508_8k.htm 8-K 14734
2 EXHIBIT 99.1 v424508_ex99-1.htm EX-99.1 88576
  Complete submission text file 0001144204-15-064448.txt   104539
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 151222197
SIC: 2834 Pharmaceutical Preparations